That's the problem with holding hands with the enemy. Eventually a joy buzzer appears and someone gets their hand stung.
I've commented before about how the friendliness of agricultural companies is a bit weird. Syngenta
Don't get me wrong; the combination of forces is good for farmers because it usually results in a superior product. And if companies can make more money from combining traits than from selling them individually, I guess investors can't complain. But the amount of friendliness among foes has always seemed a bit odd to me.
Drug companies often combine drugs in a similar fashion. Bristol-Myers Squibb
When companies set up that kind of system, there's bound to be a tussle. Monsanto and DuPont have fought in the past over one of Monsanto's other technologies, so I doubt this will be the last time someone busts out a joy buzzer.
No joking, our Foolishness is for real:
Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. Pfizer is an Inside Value recommendation. Glaxo is a former Income Investor pick. The Fool has a disclosure policy.